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of unknown significance), 0.7 versus 0.1%; ASC-H (atypical 
squamous cells with possible high-grade squamous in-
traepithelial lesions) and AGC (atypical glandular cells), 0.4 
versus 0.3%; LSIL (low-grade squamous intraepithelial le-
sions), 0.7 versus 0.3%; HSIL (high-grade squamous intraep-
ithelial lesions), 0.4 versus 0.2%, and unsatisfactory, 0.03 ver-
sus 0.08%. The LBC arm detected significantly more lesions 
(ASC-US+) than CPT (p  ! 0.001); however, when we divided 
the diagnoses into two groups, ASC-H– (negative/ASC-US/
LSIL) and ASC-H+ (ASC-H/AGC/HSIL), the difference was not 
statistically important (p = 0.213).  Conclusions: With inher-
ent difficulties in patient recruitment and patient compli-
ance with cancer screening, best test performance includ-
ing human papillomavirus test capability are vitally neces-
sary in Brazil’s struggle to reduce cervical cancer. 
 Copyright © 2012 S. Karger AG, Basel 
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 Abstract 
 Objective: It was the aim of this study to compare diagnos-
tic performances of the BD SurePath TM liquid-based Papani-
colaou test (LBC) and the conventional Papanicolaou test 
(CPT) in cervical samples of women from remote rural areas 
of Brazil.  Study Design: Specimens were collected by mo-
bile units provided by Barretos Cancer Hospital. This report 
evaluates the manual screening arm of the RODEO study. Of 
12,048 women seen between May and December 2010, 
6,001 were examined using LBC and 6,047 using CPT.  Re-
sults: Comparative (LBC vs. CPT) outcomes were: all abnor-
mal tests, 2.1 versus 1.0%; ASC-US (atypical squamous cells 
 Received: July 2, 2012 
 Accepted after revision: August 29, 2012 
 Published online: December 6, 2012 
 Correspondence to: Dr. Adhemar Longatto-Filho 
 Laboratory of Medical Investigation 14 
 Faculty of Medicine, University of São Paulo 
 1246-903 São Paulo (Brazil) 
 E-Mail longatto16   @   hotmail.com 
 © 2012 S. Karger AG, Basel
0001–5547/13/0571–0069$38.00/0 
 Accessible online at:
www.karger.com/acy 
 J.H.T.G.F. and C.S. contributed equally to this work. 
 1 Adriana Cruvinel Carloni a , Naiara Correa Nogueira-de-Souza a , Maíra 
Stein a , Fábio de Paula Mateus a , Eduardo Tadeu da Silva a , Michele M. Castro 
Alves a , Fábio Cardoso de Lima a , Erlaine Martins Suriano a . 
 Fregnani  /Scapulatempo  /Haikel/Saccheto  /
Campacci  /Mauad  /Longatto-Filho  
 Acta Cytologica 2013;57:69–74 70
 Introduction 
 Cervical cancer prevention can be likened to a three-
legged stool, with the seat representing cancer reduction 
and the legs comprising patient access  [1] , accurate and 
reliable testing  [2] , and a responsive medical infrastruc-
ture  [1, 3] . Brazil’s geography and the socioeconomic de-
pression of rural Brazil challenge public health authori-
ties charged with reducing cervical cancer  [2] .
 Barretos Cancer Hospital remains among Brazil’s 
most active cancer hospitals, and in answering geograph-
ic challenges, the hospital has, for decades, used mobile 
units (MUs) to enable the collection and preparation of 
patient samples, colposcopy examinations and minor 
surgical procedures. Under the auspices of the hospital 
and with the cooperation of local government authori-
ties, physicians, nurses and ancillary service profession-
als work with community agents to recruit and educate 
target populations for cancer prevention programs  [3] .
 Due in part to its historical role in reducing cervical 
cancer prevalence in the late 1950s and 1960s, the con-
ventional Papanicolaou (Pap) test (CPT) is Brazil’s bench-
mark cervical cancer screening test. Unfortunately, inci-
dence and mortality of cervical cancer remain high 
among Brazil’s rural poor, and failure to remedy this sit-
uation lies in part with collecting, preparing and fixing 
cervical cytology samples, whose simplicity has been 
overstated and whose complexity has been underappreci-
ated  [4, 5] . The BD SurePath TM liquid-based Pap test 
(LBC) standardizes fixation, slide preparation and slide 
staining. It is a technical advancement that also opens the 
door for computer-assisted slide analysis, human papil-
lomavirus detection and other molecular testing  [6] . The 
RODEO study will evaluate the impact of MU-based LBC 
on cervical disease detection, and this publication offers 
preliminary results of the implementation of LBC.
 Material and Methods 
 Study Design 
 RODEO is a prospective multi-center study evaluating 30,000 
women from Barretos Cancer Hospital (Barretos, Brazil) as well 
as from Leonor Mendes de Barros Hospital and Hospital das 
Clínicas of São Paulo State University (São Paulo, Brazil). It is in-
tended to offer best practices for the control and prevention of 
cervical cancer among Brazilian women, especially among those 
from impoverished, generally rural, high-risk areas including re-
gions of the Amazon River basin. The current report offers pre-
liminary data of conventional and direct-to-vial collections ob-
tained by the MUs of Barretos Cancer Hospital (fig. 1).
 Eligibility Criteria and Consent 
 Women were considered eligible for the study if their clinical 
assessment allowed for cervical cytological examination. Partici-
pants gave informed consent to participate in the study protocol 
that was approved by the ethics committee of Barretos Cancer 
Hospital (No. 244/2009).
 Group Allocation 
 The first examination of the day was random sampling; there-
after, sampling alternated in accordance with the time of day (e.g. 
morning or afternoon). When the MUs remained in an area for 
several days, LBC and CPT samplings were performed on alter-
nate days.
 Sample Collection and Preparation 
 The CPT sample was collected with a wooden Ayre spatula 
and a Rovers  Cervex-Brush  Combi, smeared on a glass slide 
and spray fixed. The LBC sample was collected with a Rovers Cer-
vex-Brush Combi, transferred into an LBC fixative and sent to the 
laboratory, where slides were prepared according to the manufac-
turer’s instructions.
 Cytological Interpretation 
 The cytology classification system of Brazil reflects the 2001 
Bethesda System  [7] .
 Statistical Analysis 
 Data were exported to SPSS for Windows  version 17.0 (SPSS 
Inc., Chicago, Ill., USA). The t test was used to compare women’s 
ages. Differences between the two sampling systems were com-
pared using the   2 and Fisher’s exact test, with significance lev-
els set at 5%. Confidence intervals for proportions were calcu-
lated.
 Results 
 The study set comprised 12,048 consecutively exam-
ined women. The study interval was from May to Decem-
ber 2010. 6,001 (49%) individuals, with a mean age of 46.5 
 8 12.5 years, were examined using LBC, and 6,047 (51%) 
individuals, with a mean age of 46.1  8 13.3 years, were 
examined using CPT.
 The geographic distribution of source material from 
seven Brazilian states was as follows: Acre (0.24%), Goiás 
(1.68%), Minas Gerais (2.71%), Mato Grosso do Sul 
(3.11%), Mato Grosso (27.9%), Rondônia (8.31%) and São 
Paulo (55.97%) (fig. 2).
 Comparative (LBC vs. CPT) outcomes were: all nor-
mals, 97.9 versus 99.0%; all abnormals, 2.1 versus 1.0%; 
unsatisfactory tests, 0.03 versus 0.08%. Data are further 
detailed in  table 1 .  Table 2 presents the frequency of neg-
ative + ASC-US (atypical squamous cells of unknown sig-
nificance) + LSIL (low-grade squamous intraepithelial le-
sions) and ASC-H (atypical squamous cells with possible 
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high-grade squamous intraepithelial lesions) + AGC 
(atypical glandular cells) + HSIL (high-grade squamous 
intraepithelial lesions), according to the type of cytology 
preparation: 99.2 and 0.8% for LBC and 99.4 and 0.6% for 
CPT, respectively.  Table 3 shows the distribution of LBC 
cytology results according to the study period. There was 
a clear reduction in ASC-US as the study progressed. A 
similar pattern was observed for ASC-H.
 Discussion 
 In Brazil, the cervical cancer screening and control 
program has been implemented at the national level more 
than 30 years ago. Various authors have observed that for 
the country as a whole, mortality from cervical cancer 
has remained virtually stable. Cervical cancer is ranked 
second among the leading causes of death from cancer in 
Brazil’s female population, with a downward trend for the 
country as a whole, a decline in the State capitals, but a 
stable trend among its interior municipalities  [8] .
 Methodological advances have proven essential to out-
come improvement in gynecological cytology and cancer 
prevention. The CPT performance falls short of that of 
LBC. The main reasons for the improved performance of 
LBC are the control of fixation, cell transfer (with the ran-
domized distribution of abnormal cells) and presenta-
tion, affording uniform and consistently stained mono-
layers  [4] .
 In the hands of seasoned health care providers, as ex-
emplified by the members of the MU teams, LBC ap-
peared to outperform CPT. Larger sample sizes (compris-
ing around 27,500–34,500 patients in each arm) would be 
needed to demonstrate statistically improved detection of 
abnormal tests (ASC-H and higher) and a meaningful re-
duction in unsatisfactory samples. Likewise, although 
HSIL appears twice as often in the LBC group, a statisti-
cally valid separation requires larger sample sizes. 
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 ASC-US was reported more frequently in the LBC arm 
of the study (0.7 vs. 0.1%); however, with increasing experi-
ence, there was a clear decrease in ASC-US reporting, and 
this was interpreted as a learning curve effect. If ASC-US 
and ASC-H are not taken into consideration, the LSIL + 
HSIL proportions for LBC remain twice that of CPT (1.1 vs. 
0.5%). Among high-risk Brazilian women, LBC has been 
shown to outperform CPT  [9] ; however, its superiority has 
not been borne out among low-risk women  [9–12] . None-
theless, in the setting of a community whose population 
numbers in the millions, small proportional differences 
equate to significant differences among actual patients.
Table 3.  Distribution of cytology results according to the study period
Cytology
result (LBC)
N umber of cases in respective study periods Total
^1,000 1,001–2,000 2,001–3,000 3,001–4,000 4,001–5,000 >5,000
Negative 969 (16.5) 983 (16.7) 980 (16.7) 971 (16.5) 978 (16.7) 990 (16.9) 5,871 (100.0)
ASC-US 15 (38.5) 8 (20.5) 4 (10.3) 5 (12.8) 4 (10.3) 3 (7.7) 39 (100.0)
ASC-H 6 (25.0) 3 (12.5) 3 (12.5) 8 (33.3) 3 (12.5) 1 (4.2) 24 (100.0)
LSIL 6 (14.6) 3 (7.3) 9 (22.0) 8 (19.5) 11 (26.8) 4 (9.8) 41 (100.0)
HSIL 4 (18.2) 1 (4.5) 4 (18.2) 8 (36.4) 3 (13.6) 2 (9.1) 22 (100.0)
Figures in parentheses are percentages.
Table 1.  Overall distribution of cytological examination according to the type of cytology preparation and the 2001 Bethesda System 
classification
Pap
test result 
Type of cytology preparation
LBC C PT
n % 95% CI n % 95% CI
Negative 5,872 97.9 95.4–100 5,981 99.0 96.5–100
ASC-US 39 0.7 0.5–0.9 6 0.1 0.04–0.2
ASC-H 24 0.4 0.3–0.6 21 0.3 0.2–0.5
LSIL 41 0.7 0.5–0.9 19 0.3 0.2–0.5
HSIL 22 0.4 0.2–0.6 14 0.2 0.1–0.4
AGC 1 0.02 0.004–0.09 1 0.02 0.004–0.09
Total 5,999 100.0 – 6,042 100.0 –
Uns atisfactory cases were excluded. 95% CI = 95% Confidence interval for proportions. 2 test, p < 0.001.
Pap test result T ype of cytology
LBC CPT
ASC-H–(negative/ASC-US/LSIL) 5,952 (99.2) 6,006 (99.4)
ASC-H+(ASC-H/AGC/HSIL) 47 (0.8) 36 (0.6)
Total 5,999 (100.0) 6,042 (100.0)
Fi gures in parentheses are percentages. Prevalence rate = 1.3, p = 0.213 (2 test).
Table 2. D istribution of Pap test results 
according to the type of cytology 
preparation
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 Unfortunately, this study also exposes a dark side to 
cytology screening in Brazil. For the sake of comparison, 
mortality from cervical cancer in Victoria (Australia) de-
clined gradually over time, and since 2002, it has been 
around 1.0 per 100,000 women (1.4 per 100,000 women 
for Australia as a whole; 2008 International Cancer 
Screening Network data of the US National Cancer Insti-
tute), which is among the lowest cervical cancer death 
rates in the world. Over the same interval, Brazil’s mor-
tality rate was about 10.9 per 100,000 women – more than 
10-fold greater than that of Victoria. However, one must 
take into consideration that there are differences in inci-
dence and mortality depending on how the data are col-
lected. There is urgent need to improve the quality of 
population-based cancer registries in low-income coun-
tries  [13] .
 One of the most disturbing aspects of this preliminary 
report, and one that should affect Brazil’s approach to 
cervical cancer screening, is that preliminary data show 
an alarmingly high ‘negative’ rate, regardless of the mode 
of cytological screening (97.9% for LBC and 99.0% for 
CPT). Of unequivocal abnormal diagnoses, the reported 
data show a HSIL + LSIL rate of between 1.1 and 0.5% 
(based on both LBC and CPT diagnoses). These out-
comes, compared to the 2010 results of the Victorian Cer-
vical Cytology Registry, showed that the proportion of 
Pap tests with identical squamous cell abnormalities was 
6.4% – a rate between 5- and 12-fold higher for Australian 
as compared to Brazilian women at a time when cervical 
cancer was 10-fold lower for Australian versus Brazilian 
women  [14] . The reasons for the low rates of cytological 
alterations detected at screening are certainly ample and 
complex, but we can hypothesize that differences in cer-
vical lesion prevalence (very low) in rural areas could in-
fluence the Pap performance. Furthermore, the low sen-
sitivity of the Pap test is well recognized even in optimal 
scenarios. On the other hand, the training of all profes-
sionals involved in screening programs based on cytolo-
gy could be revised, the theoretical issues amplified and 
periodical re-training programs considered to increase 
the quality of sample collection and preparation, as well 
as the slide analyses. Moreover, formal examination of 
theory and practice could be implemented with rigid pro-
ficiency exams. The workload should be officially estipu-
late to 40–50 slides per day. Currently, there are only rec-
ommendations for best practices, and the cytotechni-
cians are free to read more than that for 8 h. The skills 
and salaries of cytotechnicians could also be raised. How-
ever, all these options will certainly increase the very low 
prices of Pap tests in Brazil. We are now aiming for a new 
concept of cytological screening in Barretos Cancer Hos-
pital, and the introduction of LBC is a first step to im-
prove quality. Investments in the education of cytotech-
nicians are also being implemented by integrating these 
professionals in graduation courses. The augmented fre-
quency of HSIL in the LBC arm certainly endorses the 
next steps that comprise automation for reading slides 
(Focalpoint BD system is under evaluation) and improve-
ments in the internal quality control system for cytologi-
cal diagnoses that is currently based on the revision of 
10% of negative cases and the revision of all ASC-US+ 
cases.
 Given the current astronomical discrepancies on cy-
tological alteration frequencies, one wonders whether 
Brazil should ‘read the writing on the proverbial wall’ and 
altogether abandon gynecological cytology screening in 
favor of high-risk human papillomavirus testing, which 
has shown great promise among Latin American and 
Eastern European populations as a stand-alone detection 
method for cervical cancer and its immediate precursors, 
cervical intraepithelial neoplasia 2 and 3  [15] .
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  Erratum 
 In the article by Fregnani et al., entitled ‘Could alarmingly high rates of negative diag-
noses in remote rural areas be minimized with liquid-based cytology? Preliminary results 
from the RODEO Study Team’ [Acta Cytologica 2013;57:69–74, DOI: 10.1159/000343046], 
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